DEY® Labs CYANOKIT® Antidote Occupational Selection

Dey, L.P.
DEY ^® develops, manufactures, and markets innovative airway, allergy and emergency medications that save and improve lives. The Company puts "patients first" through integrated healthcare delivery solutions, and facilitates efficient, cost-effective partnerships with its customers. DEY ^® is committed to investing in its employees and the communities in which they live. Additional information about DEY ^® is available at:

www.dey.com

Indication
CYANOKIT^® Antidote is indicated for the treatment of known or suspected cyanide poisoning. If clinical suspicion of cyanide poisoning is high, CYANOKIT^® Antidote should be administered without delay.

Important Safety Information
Prior to administration of CYANOKIT^® Antidote, smoke-inhalation victims should be assessed for: exposure to fire or smoke in an enclosed area; presence of soot around the mouth, nose or oropharynx; altered mental status. Use caution in the management of patients with known anaphylactic reactions to hydroxocobalamin or cyanocobalamin. Allergic reactions may include: anaphylaxis, chest tightness, edema, urticaria, pruritus, dyspnea, and rash. Most common adverse reactions (>5%) are transient and include chromaturia (red-colored urine), erythema (skin redness), rash, increased blood pressure, nausea, headache, decreased lymphocyte percent, and injection site reactions. Usage may interfere with some clinical laboratory evaluations. If the decision is made to administer another antidote with CYANOKIT^Â®, these drugs should not be administered in the same IV line. The safety of simultaneous administration has not been established.